The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,968.00
Bid: 1,966.00
Ask: 1,968.00
Change: -5.00 (-0.25%)
Spread: 2.00 (0.102%)
Open: 1,972.00
High: 1,982.00
Low: 1,949.00
Prev. Close: 1,973.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Jefferies Cuts Diageo, Goldman Cuts Hikma

Fri, 24th Apr 2020 09:38

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:

----------

FTSE 100

----------

JEFFERIES CUTS DIAGEO TO 'UNDERPERFORM' (HOLD) - PRICE TARGET 2200 (2800) PENCE

----------

GOLDMAN SACHS CUTS HIKMA PHARMACEUTICAL TO 'NEUTRAL' ('BUY') - TARGET 2400 (2200) PENCE

----------

SOCIETE GENERALE CUTS MEGGITT TO 'SELL' ('HOLD') - TARGET 205 (610) PENCE

----------

SOCIETE GENERALE RAISES BAE SYSTEMS TO 'BUY' ('HOLD') - TARGET 550 (705) PENCE

----------

SOCIETE GENERALE CUTS ROLLS-ROYCE TO 'SELL' (HOLD) - PRICE TARGET 246 (700) PENCE

----------

CREDIT SUISSE CUTS NEXT TO 'UNDERPERFORM' ('NEUTRAL') - PRICE TARGET 4150 (4300) PENCE

----------

INVESTEC RAISES ROYAL BANK OF SCOTLAND TO 'BUY' ('HOLD') - TARGET 135 (140) PENCE

----------

BERENBERG CUTS MEGGITT PRICE TARGET TO 295 (340) PENCE - 'HOLD'

----------

MORGAN STANLEY CUTS JUST EAT TAKEAWAY.COM PRICE TARGET TO 8800 (9110) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS COMPASS GROUP PRICE TARGET TO 1540 (1930)P - 'EQUAL-WEIGHT'

----------

SOCIETE GENERALE CUTS INTERNATIONAL CONSOLIDATED AIRLINES PRICE TARGET TO 460 (520) PENCE - 'BUY'

----------

HSBC CUTS AVEVA GROUP PRICE TARGET TO 3010 (3190) PENCE - 'REDUCE'

----------

BARCLAYS CUTS EASYJET PRICE TARGET TO 650 (1400) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS CUTS UNILEVER PRICE TARGET TO 4200 (4420) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS CUTS SMITHS GROUP PRICE TARGET TO 1375 (1935) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS INTERNATIONAL CONSOLIDATED AIRLINES PRICE TARGET TO 377 (763) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS CUTS UNILEVER PRICE TARGET TO 4800 (4900) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS ITV PRICE TARGET TO 88 (98) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES JUST EAT TAKEAWAY.COM PRICE TARGET TO 9847 (7812) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

CREDIT SUISSE RAISES MARKS & SPENCER TO 'OUTPERFORM' ('UNDERPERFORM') - PRICE TARGET 125 (185) PENCE

----------

CITIGROUP RAISES GRAFTON GROUP TO 'BUY' ('NEUTRAL') - TARGET 750 (770) PENCE

----------

JEFFERIES RAISES BEAZLEY TO 'BUY' ('HOLD') - TARGET 575 (611) PENCE

----------

CANACCORD RAISES JUPITER FUND TO 'BUY' ('HOLD') - TARGET 249 (362) PENCE

----------

CREDIT SUISSE CUTS ELEMENTIS PRICE TARGET TO 99 (186) PENCE - 'OUTPERFORM'

----------

CITIGROUP CUTS ESSENTRA PRICE TARGET TO 295 (420) PENCE - 'NEUTRAL'

----------

CITIGROUP CUTS BRITVIC PRICE TARGET TO 850 (880) PENCE - 'BUY'

----------

CITIGROUP CUTS TRAVIS PERKINS PRICE TARGET TO 1420 (1860) PENCE - 'BUY'

----------

UBS CUTS WEIR GROUP PRICE TARGET TO 850 (1450) PENCE - 'NEUTRAL'

----------

HSBC CUTS HAYS PRICE TARGET TO 92 (105) PENCE - 'HOLD'

----------

HSBC RAISES DECHRA PHARMACEUTICA PRICE TARGET TO 3085 (3020) PENCE - 'HOLD'

----------

HSBC RAISES BODYCOTE PRICE TARGET TO 590 (585) PENCE - 'HOLD'

----------

BARCLAYS CUTS WIZZ AIR PRICE TARGET TO 3980 (4500) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS VESUVIUS PRICE TARGET TO 400 (495) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS CUTS SPECTRIS PRICE TARGET TO 2940 (3320) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS ROTORK PRICE TARGET TO 225 (330) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS CUTS IMI PRICE TARGET TO 925 (1320) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS G4S PRICE TARGET TO 120 (230) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS BODYCOTE PRICE TARGET TO 620 (670) PENCE - 'EQUAL WEIGHT'

----------

BERENBERG RAISES GVC HOLDING PRICE TARGET TO 900 (850) PENCE - 'BUY'

----------

RBC CUTS NATIONAL EXPRESS PRICE TARGET TO 350 (500) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS CAPITA GROUP PRICE TARGET TO 45 (140) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS PAYPOINT PRICE TARGET TO 800 (1280) PENCE - 'BUY'

----------

JPMORGAN CUTS VIRGIN MONEY PRICE TARGET TO 110 (160) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS CLOSE BROTHERS PRICE TARGET TO 1170 (1550) PENCE - 'NEUTRAL'

----------

UBS CUTS BEAZLEY PRICE TARGET TO 585 (650) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

PEEL HUNT RAISES TULLOW OIL TO 'BUY' ('HOLD')

----------

JPMORGAN RAISES STOCK SPIRITS TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 240 (250) P

----------

HSBC CUTS ROBERT WALTERS TO 'HOLD' ('BUY') - TARGET 350 PENCE

----------

HSBC CUTS RWS HOLDINGS PRICE TARGET TO 530 (600) PENCE - 'HOLD'

----------

HSBC CUTS BOOHOO PRICE TARGET TO 370 (375) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES BOOHOO PRICE TARGET TO 355 (250) PENCE - 'BUY'

----------

RBC RAISES BOOHOO PRICE TARGET TO 260 (200) PENCE - 'SECTOR PERFORM'

----------

HSBC RAISES FEVERTREE DRINKS PRICE TARGET TO 1860 (1330) PENCE - 'BUY'

----------

BARCLAYS CUTS RYANAIR PRICE TARGET TO 12.30 (17.10) EUR - 'OVERWEIGHT'

----------

JPMORGAN CUTS METRO BANK PRICE TARGET TO 90 (160) PENCE - 'UNDERWEIGHT'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.